Dec 15, 2025 05:40PM
Dec 15, 2025 05:39PM
Mar 13, 2025 06:07PM
Jun 17, 2024 07:00AM
Apr 29, 2024 04:46PM
Nov 9, 2023 04:05PM
Sep 18, 2023 05:23PM Jim Collins to Join Cibus Board of Directors
May 19, 2023 04:01PM
May 19, 2023 04:01PM
May 1, 2023 04:01PM
Apr 18, 2023 04:05PM
Mar 8, 2023 04:45PM
Mar 6, 2023 04:30PM
Mar 2, 2023 04:01PM Calyxt Reports Fourth Quarter 2022 Financial Results and Provides Corporate Update
Feb 15, 2023 07:30AM
Jan 17, 2023 07:10AM
Jan 17, 2023 06:30AM
Nov 3, 2022 04:01PM
Sep 22, 2022 07:00AM
Sep 1, 2022 07:00AM
May 12, 2022 04:31PM Cellectis Provides Business Update and Reports Financial Results for First Quarter 2022
May 5, 2022 04:14PM
May 5, 2022 04:01PM
Apr 27, 2022 02:44AM
Jan 6, 2022 05:25PM
Jul 27, 2021 04:01PM
Apr 6, 2021 08:30AM
Aug 17, 2020 02:55PM Proactive Virtual Event Brings Together a Quartet of Innovative Growth Companies
Aug 5, 2020 04:30PM
May 18, 2020 04:30PM
Jan 21, 2020 08:35AM
Jan 21, 2020 08:31AM
Nov 6, 2019 04:47PM
Sep 26, 2019 09:01AM
Aug 6, 2019 08:45PM Calyxt Reports 2nd Quarter Financial Results
Sep 17, 2018 04:30PM
Mar 6, 2017 04:30PM
Nov 22, 2016 05:00PM
Sep 8, 2016 05:30PM
May 11, 2016 05:00PM
Mar 14, 2016 05:19PM
Nov 19, 2015 02:00AM Servier Exercises Exclusive Worldwide Licensing Option with Cellectis for UCART19, an Allogeneic CAR-T Cell Therapy for Hematological Malignancies
Nov 5, 2015 09:00AM
Oct 28, 2015 05:00PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All